Biomarker analyses from early-phase studies revealed associations between response to ICIs and high baseline tumor-infiltrating lymphocytes (TILs) or early on-treatment increase in PD-L1 expression, particularly on immune rather than tumor cells, supporting the concept that immune infiltration is also pivotal for response to immunotherapy in CCA [103,119]. Here, CD274 is linked to neoplasm.